The best Bull and Bear pitches based on recency and number of recommendations.
The company's making progress on developing drugs that interfere with gene expression, and results for its lead drug, tazemetostat, appear strong. It's being evaluated for use in molecularly defined solid tumors and non-Hodgkin lymphoma, and it's… More
There are no pitches that meet the Top Bear criteria. Explain
If this upsets you, start recommending pitches below!
Read the most recent pitches from players about EPZM.DL.
Find the members with the highest scoring picks in EPZM.DL.
See what the Wall Street professionals think, according to their public statements and filings.